Kyverna Therapeutics Inc. (KYTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kyverna Therapeutics Inc.

    NASDAQ: KYTX · Real-Time Price · USD
    5.52
    -0.56 (-9.21%)
    At close: Oct 03, 2025, 3:59 PM
    5.54
    0.36%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Kyverna Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -127.48M -60.37M -28.89M -26.35M
    Depreciation & Amortization
    		 2.13M 1.71M 1.05M 586K
    Stock-Based Compensation
    		 8.36M 2.22M 929K 7.25M
    Other Working Capital
    		 7.12M -659K -7.03M -4.5M
    Other Non-Cash Items
    		 -5.12M 605K 1.41M 850K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 7.86M 3.42M -10.33M -4.49M
    Operating Cash Flow
    		 -114.25M -52.41M -36.11M -22.16M
    Capital Expenditures
    		 -2.21M -621K -768K -1.29M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -490M -54.85M -56.49M n/a
    Sales Maturities Of Investments
    		 323.64M 46.68M 43.17M n/a
    Other Investing Acitivies
    		 7.66M n/a -13.33M n/a
    Investing Cash Flow
    		 -160.9M -8.79M -14.1M -1.29M
    Debt Repayment
    		 -956K -781K -249K -41K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -3.1M -1M 175K 30K
    Financial Cash Flow
    		 337.11M 58.12M 11.88M 72.52M
    Net Cash Flow
    		 61.96M -3.08M -38.33M 49.08M
    Free Cash Flow
    		 -116.45M -53.03M -36.88M -23.44M

    Add to Watchlist